These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8083563)

  • 41. [Clinical assessment of oral ganciclovir capsules on the treatment of herpes simplex keratitis].
    Wang X; Xu JJ; LE QH; Wang Y; Wang WT
    Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):994-9. PubMed ID: 21211295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
    Liu S; Pavan-Langston D; Colby KA
    Ophthalmology; 2012 Oct; 119(10):2003-8. PubMed ID: 22796308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
    Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA
    Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis.
    Maudgal PC; Vrijghem JC; Molemans M; Missotten L
    Arch Ophthalmol; 1985 Sep; 103(9):1389-92. PubMed ID: 3929753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment.
    Balderson DE; Cai G; Fries MA; Kleinman DM; McLaughlin MM; Trivedi TM; Wurzelmann JI; Young SB
    BMC Ophthalmol; 2015 Apr; 15():42. PubMed ID: 25928630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group.
    Cornea; 2001 Mar; 20(2):123-8. PubMed ID: 11248812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
    Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation.
    Zheng X
    Cornea; 2002 Oct; 21(7 Suppl):S90-3. PubMed ID: 12484706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model.
    Wu X; Tao P; Nie H
    Clin Exp Ophthalmol; 2011 Nov; 39(8):779-83. PubMed ID: 22050565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty.
    Beyer CF; Arens MQ; Hill GA; Rose BT; Beyer LR; Schanzlin DJ
    Arch Ophthalmol; 1989 Aug; 107(8):1200-5. PubMed ID: 2547352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
    Hughes PM; Mitra AK
    J Ocul Pharmacol; 1993; 9(4):299-309. PubMed ID: 8106836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.
    Foster CS; Barney NP
    Doc Ophthalmol; 1992; 80(4):363-9. PubMed ID: 1473452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The results of using Virolex (acyclovir) in patients with herpetic keratitis].
    Babushkin AE; Mal'khanov VB
    Vestn Oftalmol; 1993; 109(5):26-8. PubMed ID: 8310597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The latest in herpes simplex keratitis therapy].
    Labetoulle M
    J Fr Ophtalmol; 2004 May; 27(5):547-57. PubMed ID: 15179314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial.
    Sozen E; Avunduk AM; Akyol N
    Chemotherapy; 2006; 52(1):29-31. PubMed ID: 16340195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acyclovir (Zovirax) ophthalmic ointment: a review of clinical tolerance.
    Grant DM
    Curr Eye Res; 1987 Jan; 6(1):231-5. PubMed ID: 3549163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraocular penetration of topically administered acyclovir.
    Kitagawa K; Fukuda M; Sasaki K
    Lens Eye Toxic Res; 1989; 6(1-2):365-73. PubMed ID: 2488028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpes simplex keratitis misdiagnosed as rheumatoid arthritis-related peripheral ulcerative keratitis.
    Zaher SS; Sandinha T; Roberts F; Ramaesh K
    Cornea; 2005 Nov; 24(8):1015-7. PubMed ID: 16227854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
    Colin J
    Clin Ophthalmol; 2007 Dec; 1(4):441-53. PubMed ID: 19668521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.